Triveni Bio
Functional antibody platform for immunological and inflammatory disorders
- Sector
- Biotech
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 40 pending
Capital timeline
No federal awards or Form D filings are on record for this company.
Many early companies raise without filing a Form D, or have not yet won a federal award. New records appear here as the sources update.
Checked: SEC EDGAR Form D through Oct 23, 2026; SBIR and STTR awards through Oct 21, 2026; USAspending contract awards
Founder? Add funding contextFounders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 40- PendingDual Inhibitor Trypsin Antibodies And Uses ThereofUSPTOApplication PCTUS2025051328
- PendingDual Inhibitor Trypsin Antibodies And Uses ThereofUSPTOApplication 19474490
- PendingKallikrein Antibodies And Uses ThereofUSPTOApplication PCTUS2025045729
Show all 40 patent records
- Dual Inhibitor Trypsin Antibodies And Uses ThereofApplication PCTUS2025051328Pending
- Dual Inhibitor Trypsin Antibodies And Uses ThereofApplication 19474490Pending
- Kallikrein Antibodies And Uses ThereofApplication PCTUS2025045729Pending
- Dual Inhibitor Kallikrein Antibodies And Uses ThereofApplication PCTUS2025045755Pending
- Dual Inhibitor Kallikrein Antibodies And Uses ThereofApplication 19163277Pending
- Kallikrein Antibodies And Uses ThereofApplication 19163226Pending
- Dual Inhibitor Trypsin Antibodies And Uses ThereofApplication 63836842Pending
- Dual Inhibitor Kallikrein Antibodies And Uses ThereofApplication 63799308Pending
- KLK5/7 + OX40 Targeting Antibodies And Uses ThereofApplication PCTUS2025014004Pending
- KLK5/7 + Tslp Targeting Antibodies And Uses ThereofApplication PCTUS2025013996Pending
- Dual Inhibitor Trypsin Antibodies And Uses ThereofApplication 63725853Pending
- Dual Inhibitor Trypsin Antibodies And Uses ThereofApplication 63708239Pending
- Kallikrein Antibodies And Uses ThereofApplication 63693694Pending
- Dual Inhibitor Kallikrein Antibodies And Uses ThereofApplication 63693626Pending
- KLK5/7 + TH2 Targeting Antibodies And Uses ThereofApplication PCTUS2024043756Pending
- KLK5/7 + IL-4 Targeting Antibodies And Uses ThereofApplication PCTUS2024043757Pending
- KLK5/7 + IL-13 Targeting Antibodies And Uses ThereofApplication PCTUS2024043759Pending
- KLK5/7 + IL-4 Targeting Antibodies And Uses ThereofApplication 63671723Pending
- KLK5/7 + IL-13 Targeting Antibodies And Uses ThereofApplication 63671694Pending
- KLK5/7 + Tslp Targeting Antibodies And Uses ThereofApplication 63671705Pending
- KLK5/7 + OX40 Targeting Antibodies And Uses ThereofApplication 63671707Pending
- Dual Inhibitor Trypsin Antibodies And Uses ThereofApplication PCTUS2024024370Pending
- Dual Inhibitor Kallikrein Antibodies And Uses ThereofApplication PCTUS2024019231Pending
- Kallikrein Antibodies And Uses ThereofApplication PCTUS2024019245Pending
- Kallikrein Antibodies And Uses ThereofApplication 63562304Pending
- ANTI-IL-13 Antibodies And Uses ThereofApplication 63744092Pending
- ANTI-IL-13 Antibodies And Uses ThereofApplication PCTUS2026010717Pending
- ANTI-IL-13 Antibodies And Uses ThereofApplication PCTUS2026010722Pending
- KLK5/7 + IL-13 Targeting Antibodies And Uses ThereofApplication PCTUS2026010728Pending
- KLK5/7 + IL-13 Targeting Antibodies And Uses ThereofApplication 63787470Pending
- KLK5/7 + IL-13 Targeting Antibodies And Uses ThereofApplication 63767423Pending
- ANTI-IL-13 Antibodies And Uses ThereofApplication 63744108Pending
- KLK5/7 + IL-13 Targeting Antibodies And Uses ThereofApplication 63744120Pending
- KLK5/7 + TH2 Targeting Antibodies And Uses ThereofApplication 63549274Pending
- Dual Inhibitor Kallikrein Antibodies And Uses ThereofApplication 63614102Pending
- KLK5/7 + TH2 Targeting Antibodies And Uses ThereofApplication 63578959Pending
- Kallikrein Antibodies And Uses ThereofApplication 63489419Pending
- Dual Inhibitor Kallikrein Antibodies And Uses ThereofApplication 63489414Pending
- KLK5/7 + OX40 Targeting Antibodies And Uses ThereofApplication 19611643Pending
- KLK5/7 + Tslp Targeting Antibodies And Uses ThereofApplication 19611657Pending
Related companies, and why
- Sienna BiopharmaceuticalsSimilar federal contract value in Biotech · null in contracts
- Vima TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Lyndra Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- First Light Biosciences Inc.Similar federal contract value in Biotech · null in contracts
- jCyte, Inc.Similar federal contract value in Biotech · null in contracts
- Theravida, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .